Why datacenter contracts are built to last and hard to escape - Bernstein
Why datacenter contracts are built to last and hard to escape - Bernstein
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
Bitcoin bulls avoided a correction as US markets opened, but analysis warned that Strategy was responsible for much of the latest BTC price strength.
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse ArticlesWhy datacenter contracts are built to last and hard to escape - Bernstein
Russian ban on Roblox gaming platform sparks rare protest
Is AI the next big threat to online retailers and food delivery?
Taking a deeper look at the massive $1T U.S. market opportunity for AVs
While Nvidia and Broadcom are both benefiting from the AI boom, Wall Street sees one stock as a much better buy. | Kaynak: www.fool.com
’Pins on a Map’: How Chicago students are tracking ICE raids
Street Calls of the Week
The final flurry of global monetary policy decisions for 2025 is likely to showcase how the easing cycle in advanced economies either lacks fresh impetus o...
Charlie Garcia responds to readers concerned about the scarcity of ultrapure water and the Japanese stocks that provide it. | Kaynak: www.marketwatch.com
The investing giant had asked the U.S. Securities and Exchange Commission to treat DeFi players like regulated entities, and the DeFi crowd pushed back. | Kaynak: www.coindesk.com
Yoga-apparel retailer’s CEO joins the ranks of departing retail executives after tumultuous year. | Kaynak: www.marketwatch.com
Biotechs are instead spending their time advancing the kind of smart science that will catch the eye of cash-rich pharmaceutical companies. | Kaynak: www.marketwatch.com